Oncology

Latest News

breast cancer | Image credit: Romolo Tavani - stock.adobe.com
New Data Show Safety of Ado-Trastuzumab, Trastuzumab Biosimilars in HER2+ Cancers

June 11th 2024

Posters from the American Society of Clinical Oncology annual meeting showcased safety and efficacy data for a trastuzumab biosimilar and an ado-trastuzumab biosimilar in HER2-positive (HER2+) cancers.

Biosimilars Check-In banner
Biosimilars Check-In: Application Acceptances, European Approvals, New Partnerships

June 6th 2024

cancer cells | Image credit: Sodapeaw - stock.adobe.com
ASCO 2024 Posters Showcase Positive Data on Denosumab, Pegfilgrastim Biosimilars

June 5th 2024

patient education | Image credit: Алексей Доненко - stock.adobe.com
Panelists Call for Consistent Education, Support to Improve Patient Comfort With Biosimilars

May 15th 2024

cancer treatment | Image credit: Monkey Business - stock.adobe.com
Cencora Analysis Shows Differences in Payer Coverage Between G-CSF Biosimilars

May 2nd 2024

Video Series
Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.